After 15d of M5D1 treatment, the lymphocytes and monocytes from tumor-bearing mice showed an average 1.7- or 1.4-fold increase in ADRB3 expression, respectively, compared with non-tumor-bearing mice. The gene discussed is ADRB3; the disease is neoplasm.